Platform Technology Partners Exact Sciences Corp Transaction History

Platform Technology Partners

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 12, 2023	BUY	$62.68 - $95.05 $165,663 - $251,217	2,643 New	2,643 $248,000
Q2 2022 Aug 04, 2022	SELL	$35.61 - $76.23 $111,922 - $239,590	-3,143 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$72.5 - $100.68 $7,975 - $11,074	-110 Reduced 3.38%	3,143 $245,000
Q2 2021 Aug 05, 2021	SELL	$93.66 - $139.27 $3,371 - $5,013	-36 Reduced 1.09%	3,253 $404,000
Q4 2020 Feb 09, 2021	SELL	$99.61 - $142.12 $398 - $568	-4 Reduced 0.12%	3,289 $436,000
Q2 2020 Nov 30, 2020	BUY	$55.75 - $92.75 $183,584 - $305,425	3,293 New	3,293 $286,000
Q1 2020 Nov 30, 2020	SELL	$37.9 - $104.44 $136,819 - $377,028	-3,610 Closed	0 $0
Q4 2019 Dec 03, 2020	BUY	$77.66 - $99.74 $280,352 - $360,061	3,610 New	3,610 $334,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Platform Technology Partners, based on Form 13F filings with the SEC.

Stay updated on Platform Technology Partners with notifications on news.